⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for mhpsc

Every month we try and update this database with for mhpsc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPCNCT05956639
Metastatic Horm...
6-month course ...
Long-term cours...
18 Years - The First Affiliated Hospital with Nanjing Medical University
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPCNCT05956639
Metastatic Horm...
6-month course ...
Long-term cours...
18 Years - The First Affiliated Hospital with Nanjing Medical University
Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPCNCT05983783
Metastatic Pros...
Hormone Sensiti...
Chemotherapy Ef...
Docetaxel
Rezvilutamide
40 Years - 80 YearsThe First Affiliated Hospital with Nanjing Medical University
Intermittent Darolutamide Treatment in the Triple Therapy of mHSPCNCT06177015
Metastatic Pros...
Intermitent Ant...
Darolutamide co...
Darolutamide in...
40 Years - 80 YearsThe First Affiliated Hospital with Nanjing Medical University
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: